Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon presents potential antiglaucoma 13-oxaprostaglandins at the ACS meeting

Aug. 31, 2001

Sumitomo claims compounds useful for neuroretinal degenerative diseases

Aug. 31, 2001

Medennium's SmartPlug receives E.U. clearance for treatment of dry eyes

Aug. 29, 2001

Visudyne approved for additional ocular conditions in the U.S.

Aug. 27, 2001

Cataracts improve with N-acetylcarnosine drops

Aug. 20, 2001

Use of beta-adrenoceptor antagonists for treating outer retina disorders described

Aug. 3, 2001

Series of adenosine antagonists reported by OSI in recent patent

July 31, 2001

New intraocular pressure-lowering agent introduced to Japanese market

July 31, 2001

Expanded use of Visudyne approved by Canadian authorities

July 30, 2001

New compounds from Alcon particularly useful for treatment of dry eye

July 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...